ISSN 1671-5411 CN 11-5329/R
Volume 17 Issue 8
Sep.  2020
Turn off MathJax
Article Contents
Francesco Rivezzi, Riccardo Vio, Claudio Bilato, Leopoldo Pagliani, Giampaolo Pasquetto, Salvatore Saccà, Roberto Verlato, Federico Migliore, Sabino Iliceto, Vito Bossone, Emanuele Bertaglia. Screening of unknown atrial fibrillation through handheld device in the elderly. J Geriatr Cardiol 2020; 17(8): 495-501. doi: 10.11909/j.issn.1671-5411.2020.08.008
Citation: Francesco Rivezzi, Riccardo Vio, Claudio Bilato, Leopoldo Pagliani, Giampaolo Pasquetto, Salvatore Saccà, Roberto Verlato, Federico Migliore, Sabino Iliceto, Vito Bossone, Emanuele Bertaglia. Screening of unknown atrial fibrillation through handheld device in the elderly. J Geriatr Cardiol 2020; 17(8): 495-501. doi: 10.11909/j.issn.1671-5411.2020.08.008

Screening of unknown atrial fibrillation through handheld device in the elderly

doi: 10.11909/j.issn.1671-5411.2020.08.008
More Information
  • Corresponding author: Emanuele Bertaglia, MD, PhD, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padova, Italy. E-mail: bertagliaferro@gmail.com
  • Received Date: 2020-04-08
  • Accepted Date: 2020-06-24
  • Rev Recd Date: 2020-05-06
  • Available Online: 2020-08-28
  • Publish Date: 2020-09-07
  •  Objective To estimate the prevalence of unknown atrial fibrillation (AF) in the elderly population of the Veneto Region, Italy. Methods 1820 patients aged ≥ 65 years with no history of AF and not anticoagulated were enrolled in primary-care settings. They underwent an opportunistic electrocardiogram screening with a handheld device (MyDiagnostick) designed to specifically detect AF. The electrocardiogram recordings were reviewed by the researchers, who confirmed the presence of AF. Results The device detected an arrhythmia in 143 patients, which was confirmed as AF in 101/143 (70.6%), with an overall prevalence of AF of 5.5% (101/1820). Prevalence of unknown AF resulted in 3.6% in patients aged 65–74 years, and 7.5% in patients age 75 or older, and increased according to CHA2DS2-VASc score: 3.5% in patients with a score of 1 or 2, 5.6% in patients with a score of 3, 7.0% in patients with a score of 4, and 7.2% in patients with a score ≥ 5. The detection rate was significantly higher in patients with mild symptoms compared to asymptomatic counterparts (24.1% vs. 4.0%, P < 0.0001). At multivariate analysis, congestive heart failure and age ≥ 75 years-old were independent predictors for screen-detected AF. Conclusions An opportunistic screening with handheld device revealed an unexpectedly high prevalence of unknown AF in elderly patients with mild symptoms. Prevalence increased with age and CHA2DS2-VASc score.
  • loading
  • [1]
    Go AS, Hylek EM, Phillips KA, et al. Prevalence of diag nosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoa gu lation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375. doi: 10.1001/jama.285.18.2370
    [2]
    Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125. doi: 10.1161/CIRCULATIONAHA.105.595140
    [3]
    Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27: 1760-1764. doi: 10.1161/01.STR.27.10.1760
    [4]
    Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the icebert. Am J Geriatr Cardiol 2005; 14: 56-61. doi: 10.1111/j.1076-7460.2005.02278.x
    [5]
    Proietti R, Alturki A, Vio R, et al. The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 2020; 21: 106-112. doi: 10.2459/JCM.0000000000000917
    [6]
    Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital- based registry (The European Community Stroke Project). Stroke 2001; 32: 392-398. doi: 10.1161/01.STR.32.2.392
    [7]
    Friberg L, Rosenqvist M, Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke 2014; 45: 2599-2605. doi: 10.1161/STROKEAHA.114.006070
    [8]
    Pisters R, van Oostenbrugge RJ, Knottnerus IL, et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010; 12: 779-784. doi: 10.1093/europace/euq080
    [9]
    Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhy thm Management (AFFIRM) study. Am Heart J 2005; 149: 657-663. doi: 10.1016/j.ahj.2004.06.032
    [10]
    Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in colla boration with EACTS. Eur Heart J 2016; 37: 2893-2962. doi: 10.1093/eurheartj/ehw210
    [11]
    January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrilla tion: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on prac tice guidelines and the Heart Rhythm Society. Circulation 2014; 130: 2071-2104. doi: 10.1161/CIR.0000000000000040
    [12]
    Fitzmaurice DA, Hobbs FD, Jowett S, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007; 335: 383. doi: 10.1136/bmj.39280.660567.55
    [13]
    Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost- effectiveness of stroke prevention through community screen ing for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost 2014; 111: 1167-1176. doi: 10.1160/TH14-03-0231
    [14]
    Kaasenbrood F, Hollander M, Rutten FH, et al. Yield of screening for atrial fibrillation in primary care with a hand- held, single-lead electrocardiogram device during influenza vaccination. Europace 2016; 18: 1514-1520. doi: 10.1093/europace/euv426
    [15]
    Tieleman RG, Plantinga Y, Rinkes D, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014; 16: 1291-1295. doi: 10.1093/europace/euu057
    [16]
    Godin R, Yeung C, Baranchuk A, et al. Screening for atrial fib rillation using a mobile, single-lead electrocardiogram in Ca nadian primary care clinics. Can J Cardiol 2019; 35: 840-845. doi: 10.1016/j.cjca.2019.03.024
    [17]
    Zwart LA, Jansen RW, Ruiter JH, et al. Opportunistic screen ing for atrial fibrillation with a single lead device in geriatric patients. J Geriatr Cardiol 2020; 17: 149-154.
    [18]
    Ramkumar S, Nerlekar N, D'Souza D, et al. Atrial fibrillation detection using single lead portable electrocardiographic mo nitoring: a systematic review and meta-analysis. BMJ Open 2018; 8: e024178. doi: 10.1136/bmjopen-2018-024178
    [19]
    Lowres N, Neubeck L, Redfern J, et al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 2013; 110: 213-222. doi: 10.1160/TH13-02-0165
    [20]
    Svennberg E, Stridh M, Engdahl J, et al. Safe automatic one- lead electrocardiogram analysis in screening for atrial fib rillation. Europace 2017; 19: 1449-1453.
    [21]
    Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, inci dence, prognosis, and predisposing conditions for atrial fib rillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N. doi: 10.1016/S0002-9149(98)00583-9
    [22]
    Proietti M, Mairesse GH, Goethals P, et al. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Europace 2016; 18: 1779-1786.
    [23]
    Engdahl J, Andersson L, Mirskaya M, et al. Stepwise screen ing of atrial fibrillation in a 75-year-old population: implica tions for stroke prevention. Circulation 2013; 127: 930-937. doi: 10.1161/CIRCULATIONAHA.112.126656
    [24]
    Hendrikx T, Hörnsten R, Rosenqvist M, et al. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord 2013; 13: 41. doi: 10.1186/1471-2261-13-41
    [25]
    Hendrikx T, Rosenqvist M, Wester P, et al. Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias. BMC Cardiovasc Disord 2014; 14: 41. doi: 10.1186/1471-2261-14-41
    [26]
    Chan PH, Wong CK, Poh YC, et al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc 2016; 5: e003428.
    [27]
    Doliwa Sobocinski P, Anggårdh Rooth E, Frykman Kull V, et al. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012; 14: 1112-1116. doi: 10.1093/europace/eur431
    [28]
    Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J 2009; 43: 163-168. doi: 10.1080/14017430802593435
    [29]
    Hendrikx T, Sundqvist M, Sandström H, et al. Atrial fib rillation among patients under investigation for suspected obstructive sleep apnea. PLoS One 2017; 12: e0171575. doi: 10.1371/journal.pone.0171575
    [30]
    Claes N, Van Laethem C, Goethals M, et al. Prevalence of atrial fibrillation in adults participating in a large-scale volun tary screening programme in Belgium. Acta Cardiol 2012; 67: 273-278. doi: 10.1080/AC.67.3.2160714
    [31]
    Samol A, Masin M, Gellner R, et al. Prevalence of unknown atrial fibrillation in patients with risk factors. Europace 2013; 15: 657-662. doi: 10.1093/europace/eus366
    [32]
    Battipaglia I, Gilbert K, Hogarth AJ, et al. Screening for atrial fibrillation in the community using a novel ECG recorder. J Atr Fibrillation 2016; 9: 1433.
    [33]
    Chan NY, Choy CC. Screening for atrial fibrillation in 13, 122 Hong Kong citizens with smartphone electrocardiogram. Heart 2017; 103: 24-31. doi: 10.1136/heartjnl-2016-309993
    [34]
    Chan NY, Choy CC, Chan CK, et al. Effectiveness of a non go vernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electro cardiogram: an observational cohort study. Hear Rhythm 2018; 15: 1306-1311. doi: 10.1016/j.hrthm.2018.06.006
    [35]
    Halcox JPJ, Wareham K, Cardew A, et al. Assessment of re mote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation 2017; 136: 1784-1794. doi: 10.1161/CIRCULATIONAHA.117.030583
    [36]
    Orchard J, Neubeck L, Freedman B, et al. eHealth tools to provide structured assistance for atrial fibrillation screening, management, and guideline-recommended therapy in metro politan general practice: the AF-SMART study. J Am Heart Assoc 2019; 8: e010959.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(4)

    Article Metrics

    Article views (252) PDF downloads(12) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return